MDxHealth Reports Q2 2025 Earnings and Strategic Updates

On August 5, 2025, NASDAQ-listed MDxHealth (Ticker: MDXH) released its financial results for the second quarter. The company's stock closed at $2.49, reflecting a slight increase of $0.02, or 0.81%, at 3:59 PM Eastern Time during regular trading hours. In extended electronic trading, the stock declined to $2.31, down by $0.18 or 7.23%, as of 7:29 PM ET. The earnings report revealed an actual EPS of -$0.15, which was slightly below the consensus estimate of -$0.13, missing by $0.02. Revenue figures for the quarter were not disclosed, and year-over-year revenue growth remains unreported. Looking ahead, MDxHealth has scheduled its Q2 2025 earnings release for August 20, 2025, with a related conference call planned for August 14, 2025, at 2:00 AM ET. Investors can anticipate additional insights, including transcripts and financial metrics, as they become available. Recent company announcements include the successful preliminary results for Q2 2025, highlighting positive adjusted EBITDA and the acquisition of the Exosome Diagnostics business from Bio-Techne. Leadership changes have also been announced, with Michael Holder appointed as Chairman of the Audit Committee and new managemen...